Angels in Life Science America | Xconomy
November 15, 2012 in Articles, Bioindustry, C-Path, Desert Angels, Technology, University Medical Center, Venture Capital by Curtis Gunn
While deal structures, return profiles, financing terms, etc. remain unknown, it is probably safe to say that angels will continue to be a cornerstone of early stage support for life science ventures. Angels’ industry and entrepreneurship experience is too valuable, their instincts and rigor in evaluating quality opportunities is too strong, and their desire to participate in the next wave of life-saving and enhancing technologies is too resilient to allow investment market conditions to remove them from the playing field.









